EP3040333
Kristallaform 5-(2,6DI-4-morfólínýl-4-pýridmídínýl)-4-tríflúrómetýlpýridín-2-amín, A PIK3-hemils
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.9.2011EP published:
12.9.2018EP application number:
16151719.8
EP translation filed:
28.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
28.9.2031Expiry date:
28.9.2025
Title:
CRYSTALLINE FORMS OF 5-(2,6-DI-4-MORPHOLINYL-4-PYRIDMIDINYL)-4-TRIFLUOROMETHYLPYRIDIN-2-AMINE, A PIK3 INHIBITOR
Timeline
Today
29.9.2011EP application
12.9.2018EP Publication
28.11.2018Translation submitted
15.12.2018Registration published
28.9.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basek, CH
Inventor
Name:
John Vincent CalienniAddress:
East Hanover , US
Name:
Marilyn De La CruzAddress:
East Hanover , US
Name:
Dletmar FlubacherAddress:
Basel, CH
Name:
Baoqing GongAddress:
East Hanover , US
Name:
Prasad Koteswara KapaAddress:
East Hanover, US
Name:
Plotr H. KarpinskiAddress:
East Hanover , US
Name:
Hul LiuAddress:
Green Brook , US
Name:
Pascal MichelAddress:
Basel, CH
Name:
Rasmus MoseAddress:
Basel, CH
Name:
Maria Caterina TestaAddress:
Basel, CH
Name:
Llladhar Murlidhar WaykoleAddress:
East Hanover , US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
388721 PDate:
1.10.2010Country:
US
Number:
201161494915 PDate:
9.6.2011Country:
US
Classification
Categories:
C07D 401/01, A61K 31/535, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 28.1.2019
Expires: 28.9.2019
Payer: Guðjón Styrkársson, hrl.
Number: 9
Paid: 19.9.2019
Expires: 28.9.2020
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 22.9.2020
Expires: 28.9.2021
Payer: Patice ehf.
Number: 11
Paid: 17.9.2021
Expires: 28.9.2022
Payer: Patice ehf.
Number: 12
Paid: 16.9.2022
Expires: 28.9.2023
Payer: Patice ehf.
Number: 13
Paid: 25.9.2023
Expires: 28.9.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 17.9.2024
Expires: 28.9.2025
Payer: Árnason Faktor ehf.